Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall J Bateman

Showing results (131-140 of 391) with videos related to

Pageof 40
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Neurology|August 3, 2019
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosisSuzanne E Schindler, James G Bollinger, Vitaliy Ovod, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersNicole S McKay, Stephanie Doering, David A Hoagey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 23, 2024
Predicting continuous amyloid PET values with CSF tau phosphorylation occupanciesJulie K Wisch, Brian A Gordon, Nicolas R Barthélemy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumNicole S McKay, Stephanie Doering, David A Hoagey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLyduine E Collij, Gemma Salvadó, Kanta Horie, et al.
Nature Communications|April 9, 2026
Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer's disease continuumLyduine E Collij, Gemma Salvadó, Kanta Horie, et al.
Science Translational Medicine|December 26, 2014
Reply to comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice"Yvette I Sheline, Tim West, Kevin Yarasheski, et al.
Nature Reviews. Neurology|September 22, 2021
The case for low-level BACE1 inhibition for the prevention of Alzheimer diseaseEric McDade, Iryna Voytyuk, Paul Aisen, et al.
Pageof 40

Showing results (131-140 of 391) with videos related to

Sort By:
Pageof 40
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Neurology|August 3, 2019
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosisSuzanne E Schindler, James G Bollinger, Vitaliy Ovod, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersNicole S McKay, Stephanie Doering, David A Hoagey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 23, 2024
Predicting continuous amyloid PET values with CSF tau phosphorylation occupanciesJulie K Wisch, Brian A Gordon, Nicolas R Barthélemy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumNicole S McKay, Stephanie Doering, David A Hoagey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLyduine E Collij, Gemma Salvadó, Kanta Horie, et al.
Nature Communications|April 9, 2026
Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer's disease continuumLyduine E Collij, Gemma Salvadó, Kanta Horie, et al.
Science Translational Medicine|December 26, 2014
Reply to comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice"Yvette I Sheline, Tim West, Kevin Yarasheski, et al.
Nature Reviews. Neurology|September 22, 2021
The case for low-level BACE1 inhibition for the prevention of Alzheimer diseaseEric McDade, Iryna Voytyuk, Paul Aisen, et al.
Pageof 40